ClientID,AdministrationID,DiagnosisID,DoseAdministered,DoseApproved,DrugName,Duration,Form,NoDosesTaken,OrderedAmount,OrderedDate,AdministeredUnits,OrderID,PatientID,ProviderID,Regimen,Route,LocationID,StartDate,StopDate,TransactionTimeStamp,VisitID,AdministrationDate
ME0001,OCH11002725168211595_249,DH_I9M1105245029_004944,250,Y,Palonosetron,0,intravenous,1,250,2013-01-14 14:15:14.000,mcg,OH_JB664888470_379,DH_HL702180949276615_26,UID_JR815404974_170,"Cyclophosphamide 250 mg/m2 and Topotecan 0.75 mg/m2 on days 1-5, every 21 days x 4 cycles",IVP,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH11002725168211595_245,2013-01-14 14:15:14.000
ME0001,OCH11002725168211595_245,DH_I9M1105245029_004944,10,Y,Dexamethasone IV,10,oral,1,10,2013-01-14 14:15:14.000,mg,OID_JB664888470_100,DH_HL702180949276615_26,UID_JR815404974_170,"Cyclophosphamide 250 mg/m2 and Topotecan 0.75 mg/m2 on days 1-5, every 21 days x 4 cycles",IV,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH11002725168211595_245,2013-01-14 14:15:14.000
ME0001,OCH11002725168211595_248,DH_I9M1105245029_004944,1.7,Y,Topotecan,30,intravenous,1,1.7,2013-01-14 14:15:14.000,mg,OID_JB664888470_180,DH_HL702180949276615_26,UID_JR815404974_170,"Cyclophosphamide 250 mg/m2 and Topotecan 0.75 mg/m2 on days 1-5, every 21 days x 4 cycles",IV,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH11002725168211595_245,2013-01-14 14:15:14.000
ME0001,OCH11002725168211595_247,DH_I9M1105245029_004944,570,Y,Cyclophosphamide,31,intravenous,1,570,2013-01-14 14:15:14.000,mg,OID_JB664888470_140,DH_HL702180949276615_26,UID_JR815404974_170,"Cyclophosphamide 250 mg/m2 and Topotecan 0.75 mg/m2 on days 1-5, every 21 days x 4 cycles",IV,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH11002725168211595_245,2013-01-14 14:15:14.000
ME0001,OCH11001665523944541_173,DH_I9M1105245029_004944,1000,Y,Granisetron IVP,0,oral,1,1000,2013-01-14 14:15:14.000,mcg,OID_MCD883941067_311,DH_HL702180949276615_26,UID_JR815404974_58,"Irinotecan 50 mg/m2 IV on days 1-5 with Vincristine 1.5 mg/m2 on days 1,8, and 15 every 28 days",IVP,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH11001665523944541_171,2013-01-14 14:15:14.000
ME0001,OCH11001665523944541_171,DH_I9M1105245029_004944,10,Y,Dexamethasone,10,oral,1,10,2013-01-14 14:15:14.000,mg,OID_MCD883941067_539,DH_HL702180949276615_26,UID_JR815404974_58,"Irinotecan 50 mg/m2 IV on days 1-5 with Vincristine 1.5 mg/m2 on days 1,8, and 15 every 28 days",IV,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH11001665523944541_171,2013-01-14 14:15:14.000
ME0001,OCH11001665523944541_172,DH_I9M1105245029_004944,0.4,Y,Atropine,0,injection,1,0.4,2013-01-14 14:15:14.000,mg,OID_MCD883941067_659,DH_HL702180949276615_26,UID_JR815404974_58,"Irinotecan 50 mg/m2 IV on days 1-5 with Vincristine 1.5 mg/m2 on days 1,8, and 15 every 28 days",IVP,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH11001665523944541_171,2013-01-14 14:15:14.000
ME0001,OCH11001665523944541_174,DH_I9M1105245029_004944,114,Y,Irinotecan,92,intravenous,1,114,2013-01-14 14:15:14.000,mg,OID_MCD883941067_779,DH_HL702180949276615_26,UID_JR815404974_58,"Irinotecan 50 mg/m2 IV on days 1-5 with Vincristine 1.5 mg/m2 on days 1,8, and 15 every 28 days",IV,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH11001665523944541_171,2013-01-14 14:15:14.000
ME0001,OCH08154207416383834_2,DH_I9M1105245029_004944,5,Y,Dexamethasone,10,oral,1,5,2013-01-14 14:15:14.000,mg,OH_MM584116637_637,DH_HL702180949276615_26,UID_BWM859942123_8,"Cyclophosphamide 250 mg/m2 and Topotecan 0.75 mg/m2 on days 1-5, every 21 days x 4 cycles",IV,LH_Jz867639801_6,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,2013-01-14 14:15:14.000,OCH08154207416383834_1,2013-01-14 14:15:14.000

